ArticleACS infectious diseases2025
Development of CGS-15943 Adjunctives for the Disruption of Plasmid Maintenance in Multidrug Resistant
Mintesinot Kassu, Katelyn E Zulauf, Jessica N Ross, James E Kirby, Roman Manetsch
Abstract read
In one paragraphArticle in ACS infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Mintesinot KassuDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
Katelyn E ZulaufDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States.
Jessica N RossDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States.
James E KirbyDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States.
Roman ManetschDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.ORCID 0000-0001-7038-6867 Funding
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1MPlasmid Eviction to Restore Susceptibility in Carbapenem-Resistant EnterobacteriaceaeR33AI119114 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KIRBY, JAMES E · 2017 to 2019
$1.5MIdentification and Characterization of Novel Antimicrobial Adjunctives to Restore Susceptibility to Carbapenem Resistant EnterobacteriaceaeF32AI124590 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SMITH, KENNETH PATRICK · 2017 to 2019
$175kNIAID NIH HHS F32 AI124590NIAID NIH HHS R33 AI119114NIAID NIH HHS T32 AI007061
6 · The paper itselfAbstract
Indexed as
Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialEscherichia coliMicrobial Sensitivity TestsPlasmidsBacterial Outer Membrane ProteinsEscherichia coli K12Escherichia coli ProteinsMembrane Transport ProteinsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsEscherichia coli ProteinsMembrane Transport ProteinstolC protein, E coliadjunctivecarbapenemasecarbapenemase producing EnterobacteralesCarbapenem resistant EnterobacteralesCGS-15943multidrug-resistanceplasmid
Identifiers
PMID39741382
PMCPMC11731274
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390